way overpriced. the market is in a bubble now on most health and tech sectors.
growth rate only 10-15% in revenue past few years. Not comparable to PNV next generation devices with 50-100% growth. Revenue already 20x revenue for the 10-15% growth a lot more growth will need to come, and historically there hasnt been this.
Aroa Biosurgery IPO, page-59
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)